In Okamoto et al's study, greater expression of IDO was confirmed not only in tumors from chemoresistant patients but also in chemoresistant ovarian cancer cell lines, suggesting that IDO may participate in chemosensitivity by intracellular mechanisms [17]. Here, IDO1 is linked to ovarian cancer.